Niagen Bioscience, Inc. (NAGE)

4.89 +0.16 (+3.38%) USD  |  NASDAQ  |  Apr 24, 11:41
More

Niagen Bioscience Return on Net Operating Assets

Return on Net Operating Assets Chart

View Return on Net Operating Assets for NAGE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Return on Net Operating Assets Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Return on Net Operating Assets Range, Past 5 Years

View Return on Net Operating Assets Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Return on Net Operating Assets Benchmarks

View Return on Net Operating Assets Benchmarks
Start Trial
SIGA Technologies, Inc. Upgrade
Nephros, Inc. Upgrade
Clover Health Investments Corp. Upgrade
Corcept Therapeutics, Inc. Upgrade
Protalix Biotherapeutics, Inc. Upgrade

Return on Net Operating Assets Related Metrics

Return on Equity Upgrade
Return on Assets Upgrade
Return on Invested Capital Upgrade
Profit Margin (Quarterly) Upgrade
Gross Profit Margin (Quarterly) Upgrade
Operating Margin (Quarterly) Upgrade